Cirugía, Pediatría, Obstetricia y Ginecología
Fachbereich
Institució Catalana de Recerca i Estudis Avançats
Barcelona, EspañaPublikationen in Zusammenarbeit mit Forschern von Institució Catalana de Recerca i Estudis Avançats (20)
2024
-
Chromosomal instability in aneuploid acute lymphoblastic leukemia associates with disease progression
EMBO molecular medicine, Vol. 16, Núm. 1, pp. 64-92
-
Integrative single-cell expression and functional studies unravels a sensitization to cytarabine-based chemotherapy through HIF pathway inhibition in AML leukemia stem cells
HemaSphere, Vol. 8, Núm. 2
-
Novel risk loci for COVID-19 hospitalization among admixed American populations
eLife, Vol. 13
2023
-
TIM3, a human acute myeloid leukemia stem cell marker, does not enrich for leukemia-initiating stem cells in B-cell acute lymphoblastic leukemia
Haematologica
-
The relapsed acute lymphoblastic leukemia network (ReALLNet): a multidisciplinary project from the spanish society of pediatric hematology and oncology (SEHOP)
Frontiers in Pediatrics, Vol. 11
2022
-
A novel and efficient tandem CD19- and CD22-directed CAR for B cell ALL
Molecular Therapy, Vol. 30, Núm. 2, pp. 550-563
-
Clonal heterogeneity and rates of specific chromosome gains are risk predictors in childhood high-hyperdiploid B-cell acute lymphoblastic leukemia
Molecular Oncology, Vol. 16, Núm. 16, pp. 2899-2919
-
Near-haploidy and low-hypodiploidy in b-cell acute lymphoblastic leukemia: When less is too much
Cancers, Vol. 14, Núm. 1
-
Novel genes and sex differences in COVID-19 severity
Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806
2021
-
Engraftment characterization of risk-stratified AML in NSGS mice
Blood Advances, Vol. 5, Núm. 23, pp. 4842-4854
2020
-
Bone marrow MSC from pediatric patients with B-ALL highly immunosuppress T-cell responses but do not compromise CD19-CAR T-cell activity
Journal for ImmunoTherapy of Cancer, Vol. 8, Núm. 2
-
Efficient elimination of primary B-ALL cells in vitro and in vivo using a novel 4-1BB-based CAR targeting a membrane-distal CD22 epitope
Journal for ImmunoTherapy of Cancer, Vol. 8, Núm. 2
2019
-
Bone marrow mesenchymal stem/stromal cells from risk-stratified acute myeloid leukemia patients are anti-inflammatory in in vivo preclinical models of hematopoietic reconstitution and severe colitis
Haematologica, Vol. 104, Núm. 2, pp. e54-e58
-
Fratricide-resistant CD1a-specific CAR T cells for the treatment of cortical T-cell acute lymphoblastic leukemia
Blood, Vol. 133, Núm. 21, pp. 2291-2304
-
NG2 antigen is a therapeutic target for MLL-rearranged B-cell acute lymphoblastic leukemia
Leukemia, Vol. 33, Núm. 7, pp. 1557-1569
2018
-
A kidney-disease gene panel allows a comprehensive genetic diagnosis of cystic and glomerular inherited kidney diseases
Kidney International, Vol. 94, Núm. 2, pp. 363-371
-
IMiDs mobilize acute myeloid leukemia blasts to peripheral blood through downregulation of CXCR4 but fail to potentiate AraC/Idarubicin activity in preclinical models of non del5q/5q- AML
OncoImmunology, Vol. 7, Núm. 9
2017
-
Detailed Characterization of Mesenchymal Stem/Stromal Cells from a Large Cohort of AML Patients Demonstrates a Definitive Link to Treatment Outcomes
Stem Cell Reports, Vol. 8, Núm. 6, pp. 1573-1586
2016
-
Development Refractoriness of MLL-Rearranged Human B Cell Acute Leukemias to Reprogramming into Pluripotency
Stem Cell Reports, Vol. 7, Núm. 4, pp. 602-618
2014
-
Bone marrow mesenchymal stem cells from patients with aplastic anemia maintain functional and immune properties and do not contribute to the pathogenesis of the disease
Haematologica, Vol. 99, Núm. 7, pp. 1168-1175